Search Within

David Chung

Formats
  1. Meeting Abstract (177)
  2. Journal Article (63)
  3. Research Letter (4)
  4. Correspondence (2)
  5. Book Section (1)
  6. Review (1)
Groups
  1. Bone Marrow Transplant (248)
  2. Center for Hematologic Malignancies (248)
  3. Department of Medicine (248)
  4. Hematologic Malignancies, Division of (248)
  5. Survivorship Research (220)
  6. Myeloma (189)

More Groups

People
  1. Sergio Giralt (207)
  2. Heather Landau (206)
  3. Alexander Lesokhin (174)
  4. Hani Hassoun (165)
  5. Gunjan Shah (155)
  6. Neha Korde (139)

More People

Years
  1. 2025 (3)
  2. 2024 (40)
  3. 2023 (40)
  4. 2022 (34)
  5. 2021 (15)
  6. 2020 (18)

More Years

Publications
  1. Blood (98)
  2. Clinical Lymphoma, Myeloma and Leukemia (44)
  3. Biology of Blood and Marrow Transplantation (28)
  4. Leukemia and Lymphoma (9)
  5. Journal of Clinical Oncology (8)
  6. Transplantation and Cellular Therapy (7)

More Publications

Publishers
  1. American Society of Hematology (103)
  2. Elsevier Inc. (82)
  3. Nature Publishing Group (13)
  4. American Association for Cancer Research (9)
  5. Taylor & Francis Group (9)
  6. American Society of Clinical Oncology (8)

More Publishers

Results (248)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-term sustained minimal residual disease (MRD) negativity in multiple myeloma patients treated with lenalidomide maintenance therapy: A clinical and correlative phase 2 study
    Meeting Abstract

    Landgren, O.; Mastey, D.; Lesokhin, A. M.; Smith, E. L.; Shah, U. A.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Salcedo, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • First description of B cell maturation antigen expression in light chain amyloidosis
    Meeting Abstract

    Bal, S.; Sigler, A.; Chan, A.; Chung, D. J.; Dogan, A.; Giralt, S. A.; Hassoun, H.; Landau, H. J.
    Blood (2019)

    Fulltext@MSK | Save
  • Reducing symptom burden in older patients with multiple myeloma (MM) using interleukin-6 (IL-6) blockage peri-autologous hematopoietic stem cell transplantation (AHCT)
    Meeting Abstract

    Shah, G. L.; Kosuri, S.; Holder, J.; Hoover, E.; Chung, D. J.; Dahi, P. B.; Scordo, M.; Landau, H.; Giralt, S. A.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Toxicity analysis of propylene glycol-free melphalan (Evomela®) compared to propylene glycol-based melphalan hydrochloride in autologous hematopoietic cell transplantation for multiple myeloma
    Meeting Abstract

    DeRespiris, L.; Bhatt, V.; Lin, A.; Maloy, M. A.; Chung, D. J.; Landau, H.; Scordo, M.; Giralt, S. A.; Shah, G. L.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Stem cell mobilization and autograft purity with novel induction regimens in multiple myeloma
    Meeting Abstract

    Bal, S.; Landau, H.; Shah, G. L.; Scordo, M.; Dahi, P. B.; Hassoun, H.; Hultcrantz, M.; Korde, N. S.; Lesokhin, A. M.; Lendvai, N.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Dendritic cells in hematopoietic cell transplantation
    Book Section

    Chung, D. J.
    In Perales, M. A.; Abutalib, S. A.; Bollard, C. (Eds.) Cell and Gene Therapies (2019)

    Fulltext@MSK | Save
  • Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy provides unprecedented MRD negativity rates in newly diagnosed multiple myeloma: A clinical and correlative phase 2 study
    Meeting Abstract

    Landgren, O.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Smith, E. L.; Shah, U. A.; Lu, S. X.; Mastey, D.; Salcedo, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • BCMA expression in AL Amyloidosis
    Meeting Abstract

    Bal, S.; Sigler, A.; Chan, A.; Chung, D.; Dogan, A.; Giralt, S.; Hassoun, H.; Landau, H.
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Interleukin-6 (IL-6) blockade with siltuximab peri-autologous hematopoietic stem cell transplantation (AHCT) may reduce symptom burden by altering the cytokine milieu in older patients with multiple myeloma (MM)
    Meeting Abstract

    Shah, G.; Holder, J.; Cho, S.; Murata, K.; Devlin, S.; Hoover, E.; Chung, D.; Dahi, P.; Lahoud, O.; Scordo, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Successful pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Shah, G.; Lin, A.; Grumley, A.; Kamrowski, A.; Schofield, R.; Devlin, S.; Bhatt, V.; Proli, A.; Chung, D.; Dahi, P.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save